DURHAM, N.C., Nov. 9, 2022 /PRNewswire/ -- Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) ...
In certain groups of men, glucose-6-phosphate dehydrogenase (G6PD) deficiency was linked with an increased likelihood of severe COVID-19, a Veterans Affairs cohort study found. In Black men under 65, ...
To test tubes, 16 by 100 mm., are added 10 mg. of sodium ascorbate § and 5 mg. of glucose. These tubes are stoppered and may be stored indefinitely at -20°C. A 2.0-ml. aliquot of whole blood ...
Editor’s note: Each week WRAL TechWire takes a deep dive into a particular company or technology or personality. Today it’s medtech. RESEARCH TRIANGLE PARK – Baebies, a medical device and diagnostics ...
In an April 8 MedPage Today article, Mark Zucker, MD, asked the question as to why there is differential susceptibility to COVID-19 infection. In other words, why do some people become severely ill ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback